RxDoctor Payments DataLook up a doctor →

Anne Campbell

Nurse Practitioner · Upland, INNPI 1528559697

Payments from drug & device makers

$10,550in general payments, 2019–2025

Across 666 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$811
  • Novo Nordisk$788
  • GSK$448
  • Amgen$354
  • plus $4K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie169$2,333
AstraZeneca66$1,454
Lilly USA, LLC75$811
Novo Nordisk47$788
GSK39$448
Amgen18$354
Boehringer Ingelheim20$329
Bayer16$300
Pfizer18$230
Otsuka America Pharmaceutical, Inc.12$229
Novartis14$217
Medtronic11$195
Idorsia Pharmaceuticals US Inc12$187
Takeda Pharmaceuticals U.S.A., Inc.12$157
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$151
Azurity Pharmaceuticals, Inc.7$144
Johnson & Johnson8$129
Exact Sciences8$128
Axsome Therapeutics, Inc.7$126
Boston Scientific2$125
E.r. Squibb & Sons, L.L.C.7$117
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$117
Arbor Pharmaceuticals, Inc.2$106
Esperion Therapeutics, Inc.6$93
Ardelyx, Inc.6$92
Biohaven Pharmaceuticals, Inc.5$91
Daiichi Sankyo Inc.4$81
Lundbeck LLC4$68
Stryker1$67
Amneal Pharmaceuticals LLC4$66
Sanofi-aventis U.S. LLC5$66
Nestle Healthcare Nutrition Inc.4$61
Astellas Pharma US Inc3$60
Merck3$48
Biohaven Pharmaceutical Holding Company Ltd.3$46
Dexcom, Inc.2$40
Axonics, Inc.2$40
Inari Medical, Inc.1$39
Amarin Pharma, Inc.2$31
Phathom Pharmaceuticals, Inc.4$28
RGH Enterprises LLC1$26
Kowa Pharmaceuticals America, Inc.2$25
Grifols USA, LLC1$24
Harmony Biosciences LLC1$23
Edwards Lifesciences1$22
IBSA Pharma Inc.1$21
Collegium Pharmaceutical, Inc.1$21
Mannkind Corporation1$20
Sumitomo Pharma America, Inc.1$20
Ironshore Pharmaceuticals Inc.1$19
Almatica Pharma LLC1$19
Vanda Pharmaceuticals Inc.1$17
Seqirus USA Inc1$16
Redhill Biopharma Inc.1$16
Philips North America LLC1$16
Teva Pharmaceuticals USA, Inc.1$14
Avion Pharmaceuticals1$13
Nevro Corp.1$12
Genentech USA, Inc.1$12

How this compares

$10,550 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$211,752
Medicare patients
386
Services billed
8,901

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Upland

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →